BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 14699650)

  • 21. Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Seneviratne C; Kupfer Y; Tessler S
    N Engl J Med; 2003 Jul; 349(4):398-400; author reply 398-400. PubMed ID: 12879892
    [No Abstract]   [Full Text] [Related]  

  • 22. Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Krishnan JA; Streiff MB
    N Engl J Med; 2003 Jul; 349(4):398-400; author reply 398-400. PubMed ID: 12879888
    [No Abstract]   [Full Text] [Related]  

  • 23. The effectiveness of warfarin dosing from a nomogram compared with house staff dosing.
    Asnis PD; Gardner MJ; Ranawat A; Leitzes AH; Peterson MG; Bass AR
    J Arthroplasty; 2007 Feb; 22(2):213-8. PubMed ID: 17275636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute physical exercise is safe in patients with primary antiphospholipid syndrome with exclusive venous thrombosis and under oral anticoagulation with warfarin.
    Garcia CB; Seguro LP; Perandini LA; de Sá Pinto AL; Lima FR; Negrão CE; Bonfa E; Borba EF
    Rheumatol Int; 2014 Dec; 34(12):1737-41. PubMed ID: 24825252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venous thrombosis as a chronic disease.
    Schafer AI
    N Engl J Med; 1999 Mar; 340(12):955-6. PubMed ID: 10089190
    [No Abstract]   [Full Text] [Related]  

  • 26. Warfarin for venous thromboembolism - walking the dosing tightrope.
    Schafer AI
    N Engl J Med; 2003 Apr; 348(15):1478-80. PubMed ID: 12601074
    [No Abstract]   [Full Text] [Related]  

  • 27. Perioperative management of oral anticoagulation.
    O'Donnell M; Kearon C
    Cardiol Clin; 2008 May; 26(2):299-309, viii. PubMed ID: 18407002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence-based initiation of warfarin (Coumadin).
    Ebell MH
    Am Fam Physician; 2005 Feb; 71(4):763-5. PubMed ID: 15742915
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence-based adjustment of warfarin (Coumadin) doses.
    Ebell MH
    Am Fam Physician; 2005 May; 71(10):1979-82. PubMed ID: 15926414
    [No Abstract]   [Full Text] [Related]  

  • 30. "Listen to the patient"--anticoagulation is critical in the antiphospholipid (Hughes) syndrome.
    Letellier E; Hughes GR
    J Rheumatol; 2003 Apr; 30(4):897. PubMed ID: 12672225
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term anticoagulation prophylaxis following acute thromboembolism.
    Hyers TM
    Dis Mon; 2005; 51(2-3):158-65. PubMed ID: 15900268
    [No Abstract]   [Full Text] [Related]  

  • 32. Warfarin-related outcomes in patients with antiphospholipid antibody syndrome managed in an anticoagulation clinic.
    Wittkowsky AK; Downing J; Blackburn J; Nutescu E
    Thromb Haemost; 2006 Aug; 96(2):137-41. PubMed ID: 16894455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [There is evidence for prolonged low-intensity warfarin therapy after venous thrombosis].
    Schulman S
    Lakartidningen; 2003 Jun; 100(24):2118-21. PubMed ID: 12841107
    [No Abstract]   [Full Text] [Related]  

  • 34. How much warfarin is enough in APS related thrombosis?
    Erkan D; Lockshin MD
    Thromb Res; 2004; 114(5-6):435-42. PubMed ID: 15507275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral anticoagulation for the antiphospholipid antibody syndrome: can we now say less is more?
    Anderson DR
    J Thromb Haemost; 2005 May; 3(5):846-7. PubMed ID: 15869574
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention of recurrent thrombosis in the antiphospholipid antibody syndrome: how long and how high with oral anticoagulant therapy?
    Baker RI
    Med J Aust; 2004 May; 180(9):436-7. PubMed ID: 15115417
    [No Abstract]   [Full Text] [Related]  

  • 37. Thrombosis prophylaxis in cancer patients with a central venous catheter.
    Laporte S; Decousus H; Mismetti P
    Arch Intern Med; 2004 Feb; 164(4):459; author reply 459-60. PubMed ID: 14980999
    [No Abstract]   [Full Text] [Related]  

  • 38. [Warfarin in the treatment of antiphospholipid syndrome].
    Reshetniak TM; Kondrat'eva LV; Patrusheva NL; Patrushev LI
    Ter Arkh; 2007; 79(5):47-54. PubMed ID: 17672075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long-term prophylaxis after venous thromboembolism].
    Gøtze JP; Friis-Hansen LJ; Thorsen S; Rehfeld JF
    Ugeskr Laeger; 2003 Jul; 165(29):2896-7. PubMed ID: 12908362
    [No Abstract]   [Full Text] [Related]  

  • 40. Evidence-based management of thrombosis in the antiphospholipid antibody syndrome.
    Petri M
    Curr Rheumatol Rep; 2003 Oct; 5(5):370-3. PubMed ID: 12967519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.